OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Bought by Franklin Resources Inc.

Franklin Resources Inc. lifted its position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 28.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 269,269 shares of the medical instruments supplier’s stock after purchasing an additional 59,723 shares during the period. Franklin Resources Inc. owned about 0.36% of OraSure Technologies worth $1,091,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of OSUR. Millennium Management LLC increased its position in shares of OraSure Technologies by 727.5% during the second quarter. Millennium Management LLC now owns 2,021,126 shares of the medical instruments supplier’s stock worth $8,610,000 after purchasing an additional 1,776,867 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in OraSure Technologies by 38.1% during the second quarter. Acadian Asset Management LLC now owns 2,195,582 shares of the medical instruments supplier’s stock worth $9,349,000 after buying an additional 605,324 shares in the last quarter. American Century Companies Inc. grew its holdings in OraSure Technologies by 30.1% in the second quarter. American Century Companies Inc. now owns 1,809,897 shares of the medical instruments supplier’s stock valued at $7,710,000 after purchasing an additional 418,603 shares during the last quarter. Renaissance Technologies LLC raised its position in OraSure Technologies by 20.6% during the second quarter. Renaissance Technologies LLC now owns 2,288,443 shares of the medical instruments supplier’s stock worth $9,749,000 after acquiring an additional 391,100 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA purchased a new stake in shares of OraSure Technologies in the second quarter valued at $1,602,000. Hedge funds and other institutional investors own 93.50% of the company’s stock.

OraSure Technologies Stock Down 0.5 %

Shares of NASDAQ OSUR opened at $3.62 on Friday. The stock has a market capitalization of $270.03 million, a PE ratio of 24.13 and a beta of 0.03. The firm has a fifty day moving average of $3.96 and a 200-day moving average of $4.16. OraSure Technologies, Inc. has a 52-week low of $3.57 and a 52-week high of $8.45.

OraSure Technologies (NASDAQ:OSUR) last announced its quarterly earnings results on Wednesday, November 6th. The medical instruments supplier reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.02. The company had revenue of $39.92 million during the quarter, compared to analyst estimates of $38.97 million. OraSure Technologies had a return on equity of 3.55% and a net margin of 5.07%. The firm’s revenue was down 55.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.27 earnings per share. Equities research analysts expect that OraSure Technologies, Inc. will post -0.08 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Monday, December 9th.

OraSure Technologies Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.